Atogepant for the Preventive Treatment of Chronic Migraine (PROGRESS): A Randomised, Double-blind, Placebo-controlled, Phase 3 Trial
Lancet 402:775-785, Pozo-Rosich,P.,et al, 2023
Atogepant for the Preventive Treatment of Migraine
NEJM 385:695-706, Ailani,J.,et al, 2021
Migraine
NEJM 383:1866-1876, Ashina, M., 2020
Migraine, hearing loss, and blurred vision in a young woman
Neurol 95:e2945-e2950, Sasikumar, S.,et al, 2020
Cyclic Vomiting Syndrome in Children
AJGH 2:doi:10.33552/AJGH.2020, Al-Ansari, N., 2020
A Woman in her 40s with Transient Neurological Symptoms, Migraine Headaches, and Hearing Loss
JAMA Neurol 76:504-505, Roshal, D.A.,et al, 2019
Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Vestibular Migraine
BMJ 366:L4213, Li, V.,et al, 2019
Acute Treatment of Migraine in Children and Adolescents
Neurol 93:487-499, Oskoui, M.,et al, 2019
Pharmacologic Treatment for Pediatric Migraine Prevention
Neurol 93:500-509, Oskoui, M.,et al, 2019
Acute Vestibular Migraine Treatment with Noninvasive Vagus Nerve Stimulation
Neurol 93:e1715-e1719, Beh, S.C. & Friedman, D.I., 2019
Abdominal Migraine
BMJ 360;k179, Angus-Leppan, H.,et al, 2018
Clinicopathologic Conference, MELAS (mitochondrial encephalopathy, lactic acidosis, and stroke like episodes)
NEJM 376:1668-1678, CASE 13-2017, 2017
Migraine
NEJM 377:553-561, Charles, A., 2017
CGRP - The Next Frontier for Migraine
NEJM 377:2190-2191, Hershey, A.D., 2017
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
NEJM 376:115-124, Powers, S.W.,et al, 2016
Evidence-Based Treatments for Adults with Migraine
Pain Reser Treat 2015:DOI:10.1155/2015/629382, Gooriah, R.,et al, 2015
Chronic Migraine
BMJ 348:g141b, Schwedt, T.J., 2014
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Reversible Cerebral Vasoconstruction Syndromes
Arch Neurol 68:1005-1012,976, Singhal, A.B.,et al, 2011
Intravenous Dihydroergotamine for Inpatient Management of Refractory Primary Headaches
Neurol 77:1827-1832, Nagy, A.J.,et al, 2011
Triptan Therapy in Migraine
NEJM 363:63-70, Loder,E., 2010
Tricyclic Antidepressants and Headaches: Systematic Review and Meta-Analysis
BMJ 341:c5222, Jackson,J.L.,et al, 2010
Botulinum Toxin Type A for the Treatment of Headache: Why We Say Yes
Arch Neurol 65:146-149,151, Ashkenazi,A. &Silberstein,S., 2008
Headache Therapy With Botulinum Toxin: Form Over Substance
Arch Neurol 65:149-151,151, Pakalnis,A. &Couch,J., 2008
Oxcarbazepine in Migraine Headache: A Double-Blind, Randomized, Placebo-Controlled Study
Neurol 70:548-555, Silberstein,S.,et al, 2008
Headache and Pregnancy
The Neurologist 14:108-119, Menon,R. &Bushnell,C.D., 2008
Sumatriptan-Naproxen for Acute Treatment of Migraine, A Randomized Trial
JAMA 297:1443-1454, Brandes,J.L.,et al, 2007
Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts & Leukoencephalopathy (CADASIL)
UpToDate (www.uptodate.com) Aug 21, Dichgans,M.,et al., 2007
Postpartum Headache: Is Your Work-Up Complete?
Am J Obstet Gynecol 196:318.e1-318.e7, Stella,C.L.,et al, 2007
Chronic Daily Headache
NEJM 354:158-165, Dodick,D.W., 2006
Phaeochromocytoma
Lancet 366:665-675, Lenders,J.W.M.,et al, 2005
Terminating Migraine with Allodynia and Ongoing Central Sensitization Using Parenteral Administration of COX1/COX2 Inhibitors
Headache 45:850-861, Jakubowski,M.,et al, 2005
Acupuncture for Chronic Headache in Primary Care: Large, Pragmatic, Randomised Trial
BMJ 328:744-747, Vickers,A.J.,et al, 2004
The Emergency Management of Headaches
The Neurologist 9:93-98, Green,M.W., 2003
Analgesic Use: A Predictor of Chronic Pain and Medication Overuse Headache
Neurol 61:160-164,154, Zwart,J.-A.,et al, 2003
10 Most Commonly Asked Questions About Which Antiplatelet Agent to Prescribe
The Neurologist 9:318-322, Adams,H.P. Jr., 2003
Association Between Migraine and Celiac Disease: Results From a Preliminary Case-Control and Therapeutic Study
, Gabrielli, M.,et al, 2003
The Safety of Triptans in the Treatment of Patients with Migraine
Am J Med 112:135-140, Jamieson,D.G., 2002
Features of Medication Overuse Headache Following Overuse of Different Acute Headache Drugs
Neurol 59:1011-1014,972, Limmroth,V.,et al, 2002
Headache
BMJ 325:881-886, Steiner,T.J. &Fontebasso,M., 2002
Prevalence of Headache in an Elderly Population: Attack Frequency, Disability, and Use of Medication
JNNP 70:377-381, Prencipe,M.,et al, 2001
What Matters is Not the Differences Between Triptans, but the Differences Between Patients
Arch Neurol 58:1481-1482, Saper,J.R., 2001
Triptans Are All Different
Arch Neurol 58:1479-1480,1482, Rapoport,A.M.&Tepper,S.J., 2001
Eletriptan in Acute Migraine:A Double-Blind,Placebo-Controlled Comparison to Sumatriptan
Neurol 54:156-163, Goadsby,P.J.,et al, 2000
Uses of Botulinum Toxin Injection in Medicine Today
BMJ 320:161-165, Munchau,A. & Bhatia,K.P., 2000
A Randomized, Double-Blind, Placebo-Controlled Study of Sumatriptan Nasal Spray in the Treatment of Acute Migraine in Adolescents
Pediatrics 106:989-997, Winner,P.,et al, 2000
Efficacy & Safety of Acetaminophen, Aspirin, and Caffeine in Alleviating Migraine Headache Pain
Arch Neurol 55:210-217, Lipton,R.B.,et al, 1998
Effectiveness of High-Dose Riboflavin in Migraine Prophylaxis, A Randomized Controlled Trial
Neurol 50:466-470, Schoenen,J.,et al, 1998